| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |